MONDAY, July 17, 2023 (HealthDay News) — Another experimental drug meant to slow the damage of Alzheimer’s appears poised to join a growing arsenal of new treatments for this memory-robbing disease. In research published online Monday in the Journal of the American Medical Association and presented simultaneously at the Alzheimer’sContinue Reading

MONDAY, July 17, 2023 (HealthDay News) — Two new studies using CRISPR gene editing offer potential new treatments for Alzheimer’s disease. “A pipeline of potential new treatments offers hope for the Alzheimer’s and dementia community,” said Maria Carrillo, chief science officer for the Alzheimer’s Association. “The progress and approvals we’veContinue Reading